Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Mayo Clin Proc. 2021 Dec 13;97(3):465–479. doi: 10.1016/j.mayocp.2021.10.004

FIGURE 4.

FIGURE 4.

Multivariable association of human immunodeficiency virus (HIV) status with incident heart failure stratified by age (A), sex (B), and race/ethnicity (C). All models are adjusted for HIV status, study site, index year, index age, sex, race/ethnicity, low income by census block, low educational level by census block, baseline smoking status, coronary revascularization, atrial fibrillation, mitral or aortic valvular disease, peripheral artery disease, diabetes, hypertension, dyslipidemia, depression, chronic liver disease, hyperthyroidism, hypothyroidism, proteinuria, alcohol abuse, drug use, estimated glomerular filtration rate, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β-blockers, calcium channel blockers, diuretics, α-adrenergic receptor agonists, aldosterone receptor antagonists, statins, nonstatin lipid therapies, anticoagulants, diabetic therapies, nonsteroidal anti-inflammatory agents, and time-updated acute coronary syndrome events. aHR = adjusted hazard ratio; CI = confidence interval.